Antitumor Effect of Bevacizumab in a Xenograft Model of Canine Hemangiopericytoma
Abstract.: Canine hemangiopericytoma (CHP) is characterized by frequent local recurrence and increased invasiveness. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis in tumors. The aim of the present study was to investigate the effect of a single dose of bevacizumab on a...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2013-01-01
|
| סדרה: | Journal of Pharmacological Sciences |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1347861319303639 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
